254 related articles for article (PubMed ID: 22019901)
1. Differences in the molecular mechanisms of adrenocortical tumorigenesis between children and adults.
Faria AM; Almeida MQ
Mol Cell Endocrinol; 2012 Mar; 351(1):52-7. PubMed ID: 22019901
[TBL] [Abstract][Full Text] [Related]
2. Insulin-like growth factor system on adrenocortical tumorigenesis.
Ribeiro TC; Latronico AC
Mol Cell Endocrinol; 2012 Mar; 351(1):96-100. PubMed ID: 22019903
[TBL] [Abstract][Full Text] [Related]
3. Molecular epidemiology of adrenocortical tumors in southern Brazil.
Custódio G; Komechen H; Figueiredo FR; Fachin ND; Pianovski MA; Figueiredo BC
Mol Cell Endocrinol; 2012 Mar; 351(1):44-51. PubMed ID: 22056871
[TBL] [Abstract][Full Text] [Related]
4. Molecular markers and long-term recurrences in a large cohort of patients with sporadic adrenocortical tumors.
Gicquel C; Bertagna X; Gaston V; Coste J; Louvel A; Baudin E; Bertherat J; Chapuis Y; Duclos JM; Schlumberger M; Plouin PF; Luton JP; Le Bouc Y
Cancer Res; 2001 Sep; 61(18):6762-7. PubMed ID: 11559548
[TBL] [Abstract][Full Text] [Related]
5. Role of the insulin-like growth factor system in adrenocortical growth control and carcinogenesis.
Fottner Ch; Hoeflich A; Wolf E; Weber MM
Horm Metab Res; 2004 Jun; 36(6):397-405. PubMed ID: 15241731
[TBL] [Abstract][Full Text] [Related]
6. Biology, clinical characteristics, and management of adrenocortical tumors in children.
Rodriguez-Galindo C; Figueiredo BC; Zambetti GP; Ribeiro RC
Pediatr Blood Cancer; 2005 Sep; 45(3):265-73. PubMed ID: 15747338
[TBL] [Abstract][Full Text] [Related]
7. Pediatric adrenocortical tumors: molecular events leading to insulin-like growth factor II gene overexpression.
Wilkin F; Gagné N; Paquette J; Oligny LL; Deal C
J Clin Endocrinol Metab; 2000 May; 85(5):2048-56. PubMed ID: 10843195
[TBL] [Abstract][Full Text] [Related]
8. High frequency of loss of heterozygosity at 11p15 and IGF2 overexpression are not related to clinical outcome in childhood adrenocortical tumors positive for the R337H TP53 mutation.
Rosati R; Cerrato F; Doghman M; Pianovski MA; Parise GA; Custódio G; Zambetti GP; Ribeiro RC; Riccio A; Figueiredo BC; Lalli E
Cancer Genet Cytogenet; 2008 Oct; 186(1):19-24. PubMed ID: 18786438
[TBL] [Abstract][Full Text] [Related]
9. Pediatric adrenocortical tumors: morphological diagnostic criteria and immunohistochemical expression of matrix metalloproteinase type 2 and human leucocyte-associated antigen (HLA) class II antigens. Results from the Italian Pediatric Rare Tumor (TREP) Study project.
Magro G; Esposito G; Cecchetto G; Dall'Igna P; Marcato R; Gambini C; Boldrini R; Collini P; D'Onofrio V; Salfi N; d'Amore E; Ferrari A; Bisogno G; Alaggio R
Hum Pathol; 2012 Jan; 43(1):31-9. PubMed ID: 21820153
[TBL] [Abstract][Full Text] [Related]
10. Transcriptome analysis reveals that p53 and {beta}-catenin alterations occur in a group of aggressive adrenocortical cancers.
Ragazzon B; Libé R; Gaujoux S; Assié G; Fratticci A; Launay P; Clauser E; Bertagna X; Tissier F; de Reyniès A; Bertherat J
Cancer Res; 2010 Nov; 70(21):8276-81. PubMed ID: 20959480
[TBL] [Abstract][Full Text] [Related]
11. Inheritance of R337H p53 gene mutation in children with sporadic adrenocortical tumor.
Sandrini F; Villani DP; Tucci S; Moreira AC; de Castro M; Elias LL
Horm Metab Res; 2005 Apr; 37(4):231-5. PubMed ID: 15952083
[TBL] [Abstract][Full Text] [Related]
12. Adrenocortical tumors in children.
Ciftci AO; Senocak ME; Tanyel FC; Büyükpamukçu N
J Pediatr Surg; 2001 Apr; 36(4):549-54. PubMed ID: 11283875
[TBL] [Abstract][Full Text] [Related]
13. Expression of insulin-like growth factor-II and its receptor in pediatric and adult adrenocortical tumors.
Almeida MQ; Fragoso MC; Lotfi CF; Santos MG; Nishi MY; Costa MH; Lerario AM; Maciel CC; Mattos GE; Jorge AA; Mendonca BB; Latronico AC
J Clin Endocrinol Metab; 2008 Sep; 93(9):3524-31. PubMed ID: 18611974
[TBL] [Abstract][Full Text] [Related]
14. [Molecular biology of incidentally diagnosed adrenal gland space-occupying lesion].
Reincke M; Allolio B
Zentralbl Chir; 1997; 122(6):430-7. PubMed ID: 9334108
[TBL] [Abstract][Full Text] [Related]
15. Prognostic impact of TP53 mutation status for adult patients with supratentorial World Health Organization Grade II astrocytoma or oligoastrocytoma: a long-term analysis.
Ständer M; Peraud A; Leroch B; Kreth FW
Cancer; 2004 Sep; 101(5):1028-35. PubMed ID: 15329912
[TBL] [Abstract][Full Text] [Related]
16. Gene expression profiling reveals a new classification of adrenocortical tumors and identifies molecular predictors of malignancy and survival.
de Reyniès A; Assié G; Rickman DS; Tissier F; Groussin L; René-Corail F; Dousset B; Bertagna X; Clauser E; Bertherat J
J Clin Oncol; 2009 Mar; 27(7):1108-15. PubMed ID: 19139432
[TBL] [Abstract][Full Text] [Related]
17. Genetics and genomics of childhood adrenocortical tumors.
El Wakil A; Doghman M; Latre De Late P; Zambetti GP; Figueiredo BC; Lalli E
Mol Cell Endocrinol; 2011 Apr; 336(1-2):169-73. PubMed ID: 21094206
[TBL] [Abstract][Full Text] [Related]
18. The molecular pathogenesis of childhood adrenocortical tumors.
Almeida MQ; Latronico AC
Horm Metab Res; 2007 Jun; 39(6):461-6. PubMed ID: 17578765
[TBL] [Abstract][Full Text] [Related]
19. Mortality rate of adrenocortical tumors in children under 15 years of age in Curitiba, Brazil.
Pianovski MA; Maluf EM; de Carvalho DS; Ribeiro RC; Rodriguez-Galindo C; Boffetta P; Zancanella P; Figueiredo BC
Pediatr Blood Cancer; 2006 Jul; 47(1):56-60. PubMed ID: 16200634
[TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factor type 1 receptor expression correlates to good prognosis in highly malignant soft tissue sarcoma.
Ahlén J; Wejde J; Brosjö O; von Rosen A; Weng WH; Girnita L; Larsson O; Larsson C
Clin Cancer Res; 2005 Jan; 11(1):206-16. PubMed ID: 15671548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
